Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.

× No keyword cloud information.

7 in total

1. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.

Authors: Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal: Antimicrob Agents Chemother Date: 2005-12 Impact factor: 5.191

Review 2. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors: Romuald Bellmann; Piotr Smuszkiewicz
Journal: Infection Date: 2017-07-12 Impact factor: 3.553

3. Penetration of amphotericin B lipid formulations into pleural effusion.

Authors: Stefan Weiler; Rosa Bellmann-Weiler; Michael Joannidis; Romuald Bellmann
Journal: Antimicrob Agents Chemother Date: 2007-09-04 Impact factor: 5.191

Review 4. Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.

Authors: Neil R H Stone; Tihana Bicanic; Rahuman Salim; William Hope
Journal: Drugs Date: 2016-03 Impact factor: 9.546

Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.

1. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.

Review 2. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

3. Penetration of amphotericin B lipid formulations into pleural effusion.

Review 4. Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.

5. Pharmacokinetics of amphotericin B colloidal dispersion in critically ill patients with cholestatic liver disease.

Review 6. Tissue penetration of antifungal agents.

Review 7. Leishmaniasis in humans: drug or vaccine therapy?